Citius Pharmaceuticals Inc (CTXR)
0.751
-0.04
(-4.94%)
USD |
NASDAQ |
Apr 19, 16:00
0.751
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 16.80M |
| December 31, 2021 | 120.47M |
| September 30, 2021 | 120.47M |
| June 30, 2021 | 129.17M |
| March 31, 2021 | 120.54M |
| December 31, 2020 | 22.90M |
| September 30, 2020 | 22.90M |
| June 30, 2020 | 20.49M |
| March 31, 2020 | 17.15M |
| December 31, 2019 | 11.13M |
| September 30, 2019 | 11.15M |
| June 30, 2019 | 13.78M |
| March 31, 2019 | 8.95M |
| December 31, 2018 | 10.71M |
| September 30, 2018 | 17.30M |
| June 30, 2018 | 14.81M |
| March 31, 2018 | 17.35M |
| December 31, 2017 | 16.42M |
| September 30, 2017 | 10.88M |
| June 30, 2017 | 4.881M |
| Date | Value |
|---|---|
| March 31, 2017 | 2.770M |
| December 31, 2016 | 6.028M |
| September 30, 2016 | 5.263M |
| June 30, 2016 | 5.258M |
| March 31, 2016 | 5.648M |
| December 31, 2015 | 1.812M |
| September 30, 2015 | 1.510M |
| June 30, 2015 | 1.129M |
| March 31, 2015 | 0.31M |
| December 31, 2014 | 0.625M |
| June 30, 2014 | 0.6324M |
| March 31, 2014 | 0.5856M |
| December 31, 2013 | 0.5953M |
| September 30, 2013 | 0.0205M |
| June 30, 2013 | 0.0185M |
| March 31, 2013 | 0.0214M |
| December 31, 2012 | 0.0182M |
| September 30, 2012 | 0.0202M |
| June 30, 2012 | 0.0199M |
| March 31, 2012 | 0.019M |
| December 31, 2011 | 0.0192M |
| September 30, 2011 | 0.0185M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
Jun 2022
129.17M
Maximum
Jun 2021
44.78M
Average
18.82M
Median
Cash from Financing (TTM) Benchmarks
| QuidelOrtho Corp | -265.80M |
| TransCode Therapeutics Inc | 2.252M |
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |
| iBio Inc | 10.68M |